Amanote Research
Register
Sign In
Clinical Use of Camptosar (CPT‐11)
Oncologist
- United States
doi 10.1634/theoncologist.2-3-191
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Medicine
Oncology
Date
June 1, 1997
Authors
Leonard B. Saltz
Publisher
Alphamed Press
Related search
Therapeutic Targeting of CPT-11 Induced Diarrhea: A Case for Prophylaxis
Current Drug Targets
Molecular Medicine
Drug Discovery
Clinical Biochemistry
Pharmacology
P7 Peptides Targeting bFGF Sensitize Colorectal Cancer Cells to CPT-11
International Journal of Molecular Medicine
Medicine
Genetics
Effect of Antivascular Endothelial Growth Factor Treatment on the Intratumoral Uptake of CPT-11
British Journal of Cancer
Cancer Research
Oncology
The Use of Neural Networks for CPT-based Liquefaction Screening
Bulletin of Engineering Geology and the Environment
Geotechnical Engineering
Engineering Geology
Geology
S-Phase Checkpoints Regulate Apo2 Ligand/Trail and CPT-11-induced Apoptosis of Prostate Cancer Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
Prolonged Deleterious Influences of Chemotherapeutic Agent CPT-11 on Resident Peritoneal Macrophages and B1 Cells
Frontiers in Immunology
Allergy
Immunology
CPT -Symmetric Universe
Physical Review Letters
Astronomy
Physics
Novel Nanoliposomal CPT-11 Infused by Convection-Enhanced Delivery in Intracranial Tumors: Pharmacology and Efficacy
Cancer Research
Cancer Research
Oncology
Bifractionated CPT-11 With LV5FU2 Infusion (FOLFIRI-3) in Combination With Bevacizumab: Clinical Outcomes in First-Line Metastatic Colorectal Cancers According to Plasma Angiopoietin-2 Levels
BMC Cancer
Cancer Research
Oncology
Genetics
